People

Patrick Chaltin

Drug-discovery investment leader and European patent attorney. He has led CD3 since its2006 inception, previously managed pharmaceutical intellectual property at KU Leuven Research & Development and holds a pharmaceutical-sciences doctorate from KU Leuven.